Cellnovo Group announced the appointment of Erwan Martin as Chief Financial Officer. Erwan replaces Thierry Moulin who has left the company to pursue other interests. Before joining Cellnovo, Erwan Martin, 48 years old, was Chief Financial Officer of Genomic Vision, a position he had held since 2009. He was also VP Corporate Development until 2015, undertaking financing operations such as the Company's initial public offering. With over 20 years of professional experience in the field of finance and biotechnology, Erwan Martin is an expert in finance and corporate development.